Clinical Trials Logo

Gastric Varices Bleeding clinical trials

View clinical trials related to Gastric Varices Bleeding.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05859009 Withdrawn - Clinical trials for Endoscopic Ultrasound

Primary Prevention of Gastric Varices Bleed

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

Primary prophylaxis of gastric varices is an important area of research, as gastric varices are a common complication of cirrhosis of the liver. Cirrhosis is a condition in which the liver becomes scarred and loses its ability to function properly, and it is a leading cause of morbidity and mortality worldwide. Gastric varices occur in up to 30% of patients with cirrhosis, and they can rupture, leading to life-threatening bleeding. The clinical, epidemiological, and public health context of primary prophylaxis of gastric varices is therefore the need to prevent the development of this complication in patients at risk for cirrhosis and to reduce the associated morbidity and mortality. The clinical trials on primary prophylaxis of gastric varices are therefore focused on evaluating the safety and efficacy of various interventions, such as beta-blockers and endoscopic techniques, in reducing the risk of gastric varices in patients with cirrhosis. The goal of this trial is to find the most effective and safe strategies for primary prophylaxis of gastric varices, in order to improve the outcomes for patients with cirrhosis.